Search

everythinglearnresearchcommunity

for

Search:↓

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

A woman had temporary hair loss due to stress from a spinal cord injury.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Trichoscopy is better than trichogram for diagnosing early female hair loss.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Imiquimod cream can rarely cause temporary hair loss.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Hair loss in women can improve with iron and vitamin supplements if caused by iron deficiency.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

New treatments for common hair loss are needed.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Most hair disorder patients at the clinic were young adult males, with alopecia areata being the most common condition.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Physical exams are important in hair loss diagnosis, considering cosmetic history, systemic diseases, and classifying alopecia types.

Androgenetic alopecia is the most common cause of hair loss at Sohag University Hospital's hair clinic.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Women without alopecia have more fat tissues and longer hair roots than those with alopecia.

Most alopecia patients were young adults with oily scalps, often linked to stress and family history.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Hair loss can occur about 4 weeks after scalp surgery but usually grows back within 3 months without treatment.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Low iron levels in the blood may be linked to chronic hair loss in women.